4.5 Article

The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates

Journal

HELIYON
Volume 7, Issue 2, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.heliyon.2021.e06167

Keywords

COVID-19; SARS-CoV-2; Mutations; Nucleocapsid Phosphoprotein (N); Infectious diseases; India

Ask authors/readers for more resources

COVID-19, caused by SARS-CoV-2, is rapidly spreading with high mutation rates, as shown by the twenty mutations found among Indian isolates. Some of these mutations impact the secondary structure of the N protein.
Coronavirus disease- 2019 (COVID-19) has rapidly become a major threat to humans due to its high infection rate and deaths caused worldwide. This disease is caused by an RNA virus, Severe Acquired Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). This class of viruses have a high rate of mutation than DNA viruses that enables them to adapt and also evade host immune system. Here, we compared the first known Nucleocapsid Phosphoprotein (N protein) sequence of SARS-CoV-2 from China with the sequences from Indian COVID-19 patients to understand, if this virus is also mutating, as it is spreading to new locations. Our data revealed twenty mutations present among Indian isolates. Out of these, mutation at six positions led to changes in the secondary structure of N protein. Further, we also show that these mutations are primarily destabilising the protein structure. The candidate mutations identified in this study may help to speed up the understanding of variations occurring in SARS-CoV-2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available